After hitting a 52-week low in November, stock market analysts are bullish on Envision Healthcare, Stock News Times reports.
Here's what you should know:
1. Nine analysts gave Envision Healthcare, trading under the symbol EVHC, a "buy" rating and one gave the company a "strong buy" rating. On the contrary, one analyst issued a "sell" rating, while six others issued "hold" ratings.
2. Credit Suisse Group was the most recent firm to analyze the stock, issuing an "outperform" rating Dec. 11.
3. The analysts' consensus target price is $47.57.
4. Envision hit a 52-week low of $23.77 in November. As of Dec. 11 at 11 a.m., Envision was trading at $32.57. Its 52-week high stands at $73.